Kenneth Rhodes - Publications

Affiliations: 
1992 Anatomy and Neurobiology Boston University, Boston, MA, United States 

0/79 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
1993 Rhodes KJ, Meiners KA, Rosene DL. A novel hinge system and incubation chamber for emulsion-coated coverslip autoradiography. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 41: 1419-27. PMID 8354882 DOI: 10.1177/41.9.8354882  0.247
1999 Bradley SR, Standaert DG, Rhodes KJ, Rees HD, Testa CM, Levey AI, Conn PJ. Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia. The Journal of Comparative Neurology. 407: 33-46. PMID 10213186 DOI: 10.1002/(SICI)1096-9861(19990428)407:1<33::AID-CNE3>3.0.CO;2-G  0.221
2006 Misonou H, Menegola M, Buchwalder L, Park EW, Meredith A, Rhodes KJ, Aldrich RW, Trimmer JS. Immunolocalization of the Ca2+-activated K+ channel Slo1 in axons and nerve terminals of mammalian brain and cultured neurons. The Journal of Comparative Neurology. 496: 289-302. PMID 16566008 DOI: 10.1002/cne.20931  0.204
2014 Atack JR, Shook BC, Rassnick S, Jackson PF, Rhodes K, Drinkenburg WH, Ahnaou A, Te Riele P, Langlois X, Hrupka B, De Haes P, Hendrickx H, Aerts N, Hens K, Wellens A, et al. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease. Acs Chemical Neuroscience. 5: 1005-19. PMID 25203719 DOI: 10.1021/cn5001606  0.202
2004 Rhodes KJ, Carroll KI, Sung MA, Doliveira LC, Monaghan MM, Burke SL, Strassle BW, Buchwalder L, Menegola M, Cao J, An WF, Trimmer JS. KChIPs and Kv4 alpha subunits as integral components of A-type potassium channels in mammalian brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 7903-15. PMID 15356203 DOI: 10.1523/JNEUROSCI.0776-04.2004  0.201
1999 Gong B, Rhodes KJ, Bekele-Arcuri Z, Trimmer JS. Type I and type II Na(+) channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. The Journal of Comparative Neurology. 412: 342-52. PMID 10441760 DOI: 10.1002/(SICI)1096-9861(19990920)412:2<342::AID-CNE11>3.0.CO;2-2  0.2
2010 Shook BC, Rassnick S, Osborne MC, Davis S, Westover L, Boulet J, Hall D, Rupert KC, Heintzelman GR, Hansen K, Chakravarty D, Bullington JL, Russell R, Branum S, Wells KM, ... ... Rhodes K, et al. In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease. Journal of Medicinal Chemistry. 53: 8104-15. PMID 20973483 DOI: 10.1021/jm100971t  0.194
1996 Rhodes KJ, Monaghan MM, Barrezueta NX, Nawoschik S, Bekele-Arcuri Z, Matos MF, Nakahira K, Schechter LE, Trimmer JS. Voltage-Gated K+Channel β Subunits: Expression and Distribution of Kvβ1 and Kvβ2 in Adult Rat Brain The Journal of Neuroscience. 16: 4846-4860. DOI: 10.1523/JNEUROSCI.16-16-04846.1996  0.191
1997 Rhodes KJ, Strassle BW, Monaghan MM, Bekele-Arcuri Z, Matos MF, Trimmer JS. Association and Colocalization of the Kvβ1 and Kvβ2 β-Subunits with Kv1 α-Subunits in Mammalian Brain K+Channel Complexes The Journal of Neuroscience. 17: 8246-8258. DOI: 10.1523/JNEUROSCI.17-21-08246.1997  0.187
2011 Peng H, Talreja T, Xin Z, Cuervo JH, Kumaravel G, Humora MJ, Xu L, Rohde E, Gan L, Jung MY, Shackett MN, Chollate S, Dunah AW, Snodgrass-Belt PA, Arnold HM, ... ... Rhodes KJ, et al. Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable γ-Secretase Modulator. Acs Medicinal Chemistry Letters. 2: 786-91. PMID 24900267 DOI: 10.1021/ml200175q  0.183
2018 Lin EYS, Silvian LF, Marcotte DJ, Banos CC, Jow F, Chan TR, Arduini RM, Qian F, Baker DP, Bergeron C, Hession CA, Huganir RL, Borenstein CF, Enyedy I, Zou J, ... ... Rhodes KJ, et al. Potent PDZ-Domain PICK1 Inhibitors that Modulate Amyloid Beta-Mediated Synaptic Dysfunction. Scientific Reports. 8: 13438. PMID 30194389 DOI: 10.1038/S41598-018-31680-3  0.182
2012 Shook BC, Rassnick S, Wallace N, Crooke J, Ault M, Chakravarty D, Barbay JK, Wang A, Powell MT, Leonard K, Alford V, Scannevin RH, Carroll K, Lampron L, Westover L, ... ... Rhodes K, et al. Design and characterization of optimized adenosine Aâ‚‚A/A₁ receptor antagonists for the treatment of Parkinson's disease. Journal of Medicinal Chemistry. 55: 1402-17. PMID 22239465 DOI: 10.1021/Jm201640M  0.179
1999 Betty M, Harnish SW, Rhodes KJ, Cockett MI. Distribution of heterotrimeric G-protein beta and gamma subunits in the rat brain. Neuroscience. 85: 475-86. PMID 9622245 DOI: 10.1016/S0306-4522(97)00623-4  0.177
2011 Shook BC, Charavarty D, Barbay JK, Wang A, Leonard K, Alford V, Powell M, Beauchamp DA, Rassnick S, Scannevin R, Carroll K, Wallace N, Crooke J, Ault M, Lampron L, ... ... Rhodes K, et al. Aminomethyl substituted thieno[2,3-d]pyrimidines as adenosine A 2A receptor antagonists Medchemcomm. 2: 950-965. DOI: 10.1039/c1md00082a  0.176
2005 Strassle BW, Menegola M, Rhodes KJ, Trimmer JS. Light and electron microscopic analysis of KChIP and Kv4 localization in rat cerebellar granule cells. The Journal of Comparative Neurology. 484: 144-55. PMID 15736227 DOI: 10.1002/cne.20443  0.175
1995 Rhodes K, Keilbaugh S, Barrezueta N, Lopez K, Trimmer J. Association and colocalization of K+ channel alpha- and beta-subunit polypeptides in rat brain The Journal of Neuroscience. 15: 5360-5371. DOI: 10.1523/JNEUROSCI.15-07-05360.1995  0.174
2015 Scannevin RH, Chollate S, Brennan MS, Snodgrass-Belt PA, Peng H, Xu L, Jung MY, Bussiere T, Arastu MF, Talreja T, Xin Z, Dunstan RW, Fahrer D, Rohde E, Dunah AW, ... ... Rhodes KJ, et al. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease. Neuropharmacology. PMID 26690893 DOI: 10.1016/j.neuropharm.2015.12.006  0.172
2014 Alfonso S, Kessels HW, Banos CC, Chan TR, Lin ET, Kumaravel G, Scannevin RH, Rhodes KJ, Huganir R, Guckian KM, Dunah AW, Malinow R. Synapto-depressive effects of amyloid beta require PICK1. The European Journal of Neuroscience. 39: 1225-33. PMID 24713001 DOI: 10.1111/Ejn.12499  0.172
2022 Tardiff DF, Lucas M, Wrona I, Chang B, Chung CY, Le Bourdonnec B, Rhodes KJ, Scannevin RH. Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson's Disease. Molecular Neurobiology. PMID 35060064 DOI: 10.1007/s12035-021-02695-1  0.17
2010 Shook BC, Rassnick S, Hall D, Rupert KC, Heintzelman GR, Hansen K, Chakravarty D, Bullington JL, Scannevin RH, Magliaro B, Westover L, Carroll K, Lampron L, Russell R, Branum S, ... ... Rhodes K, et al. Methylene amine substituted arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 2864-7. PMID 20347304 DOI: 10.1016/j.bmcl.2010.03.042  0.169
1986 Rhodes KJ, Zottoli SJ, Mufson EJ. Choline acetyltransferase immunohistochemical staining in the goldfish (Carassius auratus) brain: evidence that the Mauthner cell does not contain choline acetyltransferase. Brain Research. 381: 215-24. PMID 3530376 DOI: 10.1016/0006-8993(86)90070-3  0.165
2001 Monaghan MM, Trimmer JS, Rhodes KJ. Experimental Localization of Kv1 Family Voltage-Gated K+Channel α and β Subunits in Rat Hippocampal Formation The Journal of Neuroscience. 21: 5973-5983. DOI: 10.1523/JNEUROSCI.21-16-05973.2001  0.163
2000 An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS, Rhodes KJ. Modulation of A-type potassium channels by a family of calcium sensors. Nature. 403: 553-6. PMID 10676964 DOI: 10.1038/35000592  0.161
2022 Nuber S, Chung CY, Tardiff DF, Bechade PA, McCaffery TD, Shimanaka K, Choi J, Chang B, Raja W, Neve E, Burke C, Jiang X, Xu P, Khurana V, Dettmer U, ... ... Rhodes KJ, et al. A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 35445353 DOI: 10.1007/s13311-022-01199-7  0.161
2004 Trimmer JS, Rhodes KJ. Localization of voltage-gated ion channels in mammalian brain. Annual Review of Physiology. 66: 477-519. PMID 14977411 DOI: 10.1146/annurev.physiol.66.032102.113328  0.158
2010 Shook BC, Rassnick S, Chakravarty D, Wallace N, Ault M, Crooke J, Barbay JK, Wang A, Leonard K, Powell MT, Alford V, Hall D, Rupert KC, Heintzelman GR, Hansen K, ... ... Rhodes K, et al. Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 2868-71. PMID 20338760 DOI: 10.1016/j.bmcl.2010.03.024  0.156
2002 Holmqvist MH, Cao J, Hernandez-Pineda R, Jacobson MD, Carroll KI, Sung MA, Betty M, Ge P, Gilbride KJ, Brown ME, Jurman ME, Lawson D, Silos-Santiago I, Xie Y, Covarrubias M, ... Rhodes KJ, et al. Elimination of fast inactivation in Kv4 A-type potassium channels by an auxiliary subunit domain. Proceedings of the National Academy of Sciences of the United States of America. 99: 1035-40. PMID 11805342 DOI: 10.1073/Pnas.022509299  0.155
2016 Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, ... ... Rhodes K, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 537: 50-6. PMID 27582220 DOI: 10.1038/nature19323  0.153
2011 Xin Z, Peng H, Zhang A, Talreja T, Kumaravel G, Xu L, Rohde E, Jung MY, Shackett MN, Kocisko D, Chollate S, Dunah AW, Snodgrass-Belt PA, Arnold HM, Taveras AG, ... Rhodes KJ, et al. Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach. Bioorganic & Medicinal Chemistry Letters. 21: 7277-80. PMID 22061640 DOI: 10.1016/j.bmcl.2011.10.047  0.149
2003 Zhang ZH, Lee YT, Rhodes K, Wang K, Argentieri TM, Wang Q. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels. Brain Research. Molecular Brain Research. 115: 29-38. PMID 12824052 DOI: 10.1016/S0169-328X(03)00175-X  0.149
2004 Beyer CE, Ghavami A, Lin Q, Sung A, Rhodes KJ, Dawson LA, Schechter LE, Young KH. Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo. Brain Research. 1022: 214-20. PMID 15353231 DOI: 10.1016/j.brainres.2004.06.073  0.148
1996 Shi G, Nakahira K, Hammond S, Rhodes KJ, Schechter LE, Trimmer JS. Beta subunits promote K+ channel surface expression through effects early in biosynthesis. Neuron. 16: 843-52. PMID 8608002 DOI: 10.1016/S0896-6273(00)80104-X  0.146
2003 Shibata R, Misonou H, Campomanes CR, Anderson AE, Schrader LA, Doliveira LC, Carroll KI, Sweatt JD, Rhodes KJ, Trimmer JS. A fundamental role for KChIPs in determining the molecular properties and trafficking of Kv4.2 potassium channels. The Journal of Biological Chemistry. 278: 36445-54. PMID 12829703 DOI: 10.1074/Jbc.M306142200  0.145
2022 Nuber S, Chung CY, Tardiff DF, Bechade PA, McCaffery TD, Shimanaka K, Choi J, Chang B, Raja W, Neves E, Burke C, Jiang X, Xu P, Khurana V, Dettmer U, ... ... Rhodes KJ, et al. Correction to: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 35792968 DOI: 10.1007/s13311-022-01268-x  0.145
2001 Manganas LN, Wang Q, Scannevin RH, Antonucci DE, Rhodes KJ, Trimmer JS. Identification of a trafficking determinant localized to the Kv1 potassium channel pore. Proceedings of the National Academy of Sciences of the United States of America. 98: 14055-9. PMID 11698661 DOI: 10.1073/Pnas.241403898  0.144
2022 Raja WK, Neves E, Burke C, Jiang X, Xu P, Rhodes KJ, Khurana V, Scannevin RH, Chung CY. Patient-derived three-dimensional cortical neurospheres to model Parkinson's disease. Plos One. 17: e0277532. PMID 36454869 DOI: 10.1371/journal.pone.0277532  0.144
2008 Rhodes KJ, Trimmer JS. Antibody-based validation of CNS ion channel drug targets. The Journal of General Physiology. 131: 407-13. PMID 18411328 DOI: 10.1085/jgp.200709926  0.143
2022 Choi J, Kii H, Nelson J, Yamazaki Y, Yanagawa F, Kitajima A, Uozumi T, Kiyota Y, Doshi D, Rhodes K, Scannevin R, Sadlish H, Chung CY. AUTOMATED ALGORITHM DEVELOPMENT TO ASSESS SURVIVAL OF HUMAN NEURONS USING LONGITUDINAL SINGLE-CELL TRACKING: APPLICATION TO SYNUCLEINOPATHY. Slas Technology. PMID 36455858 DOI: 10.1016/j.slast.2022.11.003  0.142
2002 Campomanes CR, Carroll KI, Manganas LN, Hershberger ME, Gong B, Antonucci DE, Rhodes KJ, Trimmer JS. Kv beta subunit oxidoreductase activity and Kv1 potassium channel trafficking. The Journal of Biological Chemistry. 277: 8298-305. PMID 11748234 DOI: 10.1074/Jbc.M110276200  0.14
2016 Brennan MS, Patel H, Allaire N, Thai A, Cullen P, Ryan S, Lukashev M, Bista P, Huang R, Rhodes KJ, Scannevin RH. Pharmacodynamics of Dimethyl Fumarate are Tissue-specific and Involve NRF2-dependent and -independent Mechanisms. Antioxidants & Redox Signaling. PMID 26980071 DOI: 10.1089/ars.2015.6622  0.138
2005 Aimond F, Kwak SP, Rhodes KJ, Nerbonne JM. Accessory Kvbeta1 subunits differentially modulate the functional expression of voltage-gated K+ channels in mouse ventricular myocytes. Circulation Research. 96: 451-8. PMID 15662035 DOI: 10.1161/01.Res.0000156890.25876.63  0.138
1997 Brown AM, Tummolo DM, Rhodes KJ, Hofmann JR, Jacobsen JS, Sonnenberg-Reines J. Selective aggregation of endogenous beta-amyloid peptide and soluble amyloid precursor protein in cerebrospinal fluid by zinc. Journal of Neurochemistry. 69: 1204-12. PMID 9282944 DOI: 10.1046/j.1471-4159.1997.69031204.x  0.137
1998 Lombardi SJ, Truong A, Spence P, Rhodes KJ, Jones PG. Structure-activity relationships of the Kvbeta1 inactivation domain and its putative receptor probed using peptide analogs of voltage-gated potassium channel alpha- and beta-subunits. The Journal of Biological Chemistry. 273: 30092-6. PMID 9804762 DOI: 10.1074/jbc.273.46.30092  0.135
2011 Lim HK, Chen J, Sensenhauser C, Cook K, Preston R, Thomas T, Shook B, Jackson PF, Rassnick S, Rhodes K, Gopaul V, Salter R, Silva J, Evans DC. Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate. Chemical Research in Toxicology. 24: 1012-30. PMID 21667953 DOI: 10.1021/tx1004437  0.133
1988 Zottoli SJ, Rhodes KJ, Corrodi JG, Mufson EJ. Putative cholinergic projections from the nucleus isthmi and the nucleus reticularis mesencephali to the optic tectum in the goldfish (Carassius auratus). The Journal of Comparative Neurology. 273: 385-98. PMID 2463280 DOI: 10.1002/cne.902730309  0.131
1987 Rhodes KJ, Joyce JN, Sapp DW, Marshall JF. [3H]hemicholinium-3 binding in rabbit striatum: correspondence with patchy acetylcholinesterase staining and a method for quantifying striatal compartments. Brain Research. 412: 400-4. PMID 3607475 DOI: 10.1016/0006-8993(87)91151-6  0.129
2013 Shook BC, Chakravarty D, Barbay JK, Wang A, Leonard K, Alford V, Powell MT, Rassnick S, Scannevin RH, Carroll K, Wallace N, Crooke J, Ault M, Lampron L, Westover L, ... Rhodes K, et al. Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23: 2688-91. PMID 23522563 DOI: 10.1016/J.Bmcl.2013.02.078  0.127
2017 Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, ... ... Rhodes K, et al. Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 546: 564. PMID 28640269 DOI: 10.1038/nature22809  0.126
2008 Yang SM, Scannevin RH, Wang B, Burke SL, Huang Z, Karnachi P, Wilson LJ, Rhodes KJ, Lagu B, Murray WV. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents. Bioorganic & Medicinal Chemistry Letters. 18: 1140-5. PMID 18083558 DOI: 10.1016/j.bmcl.2007.11.129  0.125
2004 Scannevin RH, Wang K, Jow F, Megules J, Kopsco DC, Edris W, Carroll KC, Lü Q, Xu W, Xu Z, Katz AH, Olland S, Lin L, Taylor M, Stahl M, ... ... Rhodes KJ, et al. Two N-terminal domains of Kv4 K(+) channels regulate binding to and modulation by KChIP1. Neuron. 41: 587-98. PMID 14980207 DOI: 10.1016/S0896-6273(04)00049-2  0.125
1987 Zottoli SJ, Rhodes KJ, Mufson EJ. Comparison of acetylcholinesterase and choline acetyltransferase staining patterns in the optic tectum of the goldfish Carassius auratus. A histochemical and immunocytochemical analysis. Brain, Behavior and Evolution. 30: 143-59. PMID 3311287 DOI: 10.1159/000118643  0.124
2012 Arnold HM, Huang C, Huang R, Engber T, Rhodes K, Scannevin R. Neuroprotective Effects of BG-12 on Malonate-Induced Striatal Lesion Volume in Sprague-Dawley Rat Brain (P02.121) Neurology. 78: P02.121-P02.121. DOI: 10.1212/WNL.78.1_MeetingAbstracts.P02.121  0.124
2008 Monaghan MM, Menegola M, Vacher H, Rhodes KJ, Trimmer JS. Altered expression and localization of hippocampal A-type potassium channel subunits in the pilocarpine-induced model of temporal lobe epilepsy. Neuroscience. 156: 550-62. PMID 18727953 DOI: 10.1016/j.neuroscience.2008.07.057  0.123
2002 Beck EJ, Bowlby M, An WF, Rhodes KJ, Covarrubias M. Remodelling inactivation gating of Kv4 channels by KChIP1, a small-molecular-weight calcium-binding protein. The Journal of Physiology. 538: 691-706. PMID 11826158 DOI: 10.1113/jphysiol.2001.013127  0.122
1996 Nakahira K, Shi G, Rhodes KJ, Trimmer JS. Selective interaction of voltage-gated K+ channel beta-subunits with alpha-subunits. The Journal of Biological Chemistry. 271: 7084-9. PMID 8636142 DOI: 10.1074/jbc.271.12.7084  0.121
2002 Guo W, Li H, Aimond F, Johns DC, Rhodes KJ, Trimmer JS, Nerbonne JM. Role of heteromultimers in the generation of myocardial transient outward K+ currents. Circulation Research. 90: 586-93. PMID 11909823 DOI: 10.1161/01.Res.0000012664.05949.E0  0.12
1996 Scannevin RH, Murakoshi H, Rhodes KJ, Trimmer JS. Identification of a cytoplasmic domain important in the polarized expression and clustering of the Kv2.1 K+ channel. The Journal of Cell Biology. 135: 1619-32. PMID 8978827 DOI: 10.1083/jcb.135.6.1619  0.119
2001 Kajkowski EM, Lo CF, Ning X, Walker S, Sofia HJ, Wang W, Edris W, Chanda P, Wagner E, Vile S, Ryan K, McHendry-Rinde B, Smith SC, Wood A, Rhodes KJ, et al. beta -Amyloid peptide-induced apoptosis regulated by a novel protein containing a g protein activation module. The Journal of Biological Chemistry. 276: 18748-56. PMID 11278849 DOI: 10.1074/jbc.M011161200  0.116
2001 Holmqvist MH, Cao J, Knoppers MH, Jurman ME, Distefano PS, Rhodes KJ, Xie Y, An WF. Kinetic Modulation of Kv4-Mediated A-Current by Arachidonic Acid Is Dependent on Potassium Channel Interacting Proteins The Journal of Neuroscience. 21: 4154-4161. DOI: 10.1523/JNEUROSCI.21-12-04154.2001  0.112
2018 Vincent BM, Tardiff DF, Piotrowski JS, Aron R, Lucas MC, Chung CY, Bacherman H, Chen Y, Pires M, Subramaniam R, Doshi DB, Sadlish H, Raja WK, Solís EJ, Khurana V, ... ... Rhodes KJ, et al. Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity. Cell Reports. 25: 2742-2754.e31. PMID 30517862 DOI: 10.1016/J.Celrep.2018.11.028  0.111
2007 Lee SR, Guo SZ, Scannevin RH, Magliaro BC, Rhodes KJ, Wang X, Lo EH. Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators. Neuroscience Letters. 417: 1-5. PMID 17386975 DOI: 10.1016/j.neulet.2007.01.017  0.105
2006 Rhodes KJ, Trimmer JS. Antibodies as valuable neuroscience research tools versus reagents of mass distraction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 8017-20. PMID 16885215 DOI: 10.1523/JNEUROSCI.2728-06.2006  0.099
1999 Lombardi SJ, Truong A, Spence P, Rhodes KJ, Jones PG. Probing the potassium channel Kv beta 1/Kv1.1 interaction using a random peptide display library. Annals of the New York Academy of Sciences. 868: 427-30. PMID 10414314 DOI: 10.1111/j.1749-6632.1999.tb11306.x  0.095
2012 Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, Bista P, Zeng W, Ryan S, Yamamoto M, Lukashev M, Rhodes KJ. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. The Journal of Pharmacology and Experimental Therapeutics. 341: 274-84. PMID 22267202 DOI: 10.1124/Jpet.111.190132  0.092
1997 Trimmer JS, Rhodes KJ. Building (potassium) channels to the 21st century. Trends in Neurosciences. 20: 99-100. PMID 9061860 DOI: 10.1016/S0166-2236(96)01011-9  0.088
2008 Zhang YM, Fan X, Chakaravarty D, Xiang B, Scannevin RH, Huang Z, Ma J, Burke SL, Karnachi P, Rhodes KJ, Jackson PF. 1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke. Bioorganic & Medicinal Chemistry Letters. 18: 409-13. PMID 17981034 DOI: 10.1016/j.bmcl.2007.10.045  0.088
2015 Brennan MS, Matos MF, Li B, Hronowski X, Gao B, Juhasz P, Rhodes KJ, Scannevin RH. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. Plos One. 10: e0120254. PMID 25793262 DOI: 10.1371/journal.pone.0120254  0.087
2004 Zhang ZH, Rhodes KJ, Childers WE, Argentieri TM, Wang Q. Disinactivation of N-type inactivation of voltage-gated K channels by an erbstatin analogue. The Journal of Biological Chemistry. 279: 29226-30. PMID 15136567 DOI: 10.1074/jbc.M403290200  0.085
2008 Yang SM, Scannevin RH, Wang B, Burke SL, Wilson LJ, Karnachi P, Rhodes KJ, Lagu B, Murray WV. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification. Bioorganic & Medicinal Chemistry Letters. 18: 1135-9. PMID 18086526 DOI: 10.1016/j.bmcl.2007.11.119  0.084
2011 Mi S, Lee X, Hu Y, Ji B, Shao Z, Yang W, Huang G, Walus L, Rhodes K, Gong BJ, Miller RH, Pepinsky RB. Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nature Medicine. 17: 816-21. PMID 21725297 DOI: 10.1038/Nm.2373  0.083
2011 Wilson LJ, Wang B, Yang SM, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV. Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy. Bioorganic & Medicinal Chemistry Letters. 21: 6485-90. PMID 21925881 DOI: 10.1016/j.bmcl.2011.08.068  0.079
2017 Scannevin RH, Alexander R, Mezzasalma Haarlander T, Burke SL, Singer M, Hou C, Zhang YM, Maguire D, Spurlino J, Deckman I, Carroll KI, Lewandowski F, Devine E, Dzordzorme K, Tounge B, ... Rhodes KJ, et al. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation. The Journal of Biological Chemistry. PMID 28860188 DOI: 10.1074/Jbc.M117.806075  0.078
1988 Danielson PD, Zottoli SJ, Corrodi JG, Rhodes KJ, Mufson EJ. Localization of choline acetyltransferase to somata of posterior lateral line efferents in the goldfish. Brain Research. 448: 158-61. PMID 2455582 DOI: 10.1016/0006-8993(88)91112-2  0.078
2006 Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P. Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16: 3096-100. PMID 16632358 DOI: 10.1002/chin.200637084  0.076
2008 Zhang YM, Fan X, Yang SM, Scannevin RH, Burke SL, Rhodes KJ, Jackson PF. Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs). Bioorganic & Medicinal Chemistry Letters. 18: 405-8. PMID 17980583 DOI: 10.1016/j.bmcl.2007.10.049  0.068
2008 Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH. Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke; a Journal of Cerebral Circulation. 39: 3372-7. PMID 18927459 DOI: 10.1161/STROKEAHA.108.514026  0.068
2012 Wilson LJ, Wang B, Yang S, Scannevin RH, Burke SL, Karnachi P, Rhodes KJ, Murray WV. ChemInform Abstract: Discovery of Novel Cobactin-T Based Matrix Metalloproteinase Inhibitors via a Ring Closing Metathesis Strategy. Cheminform. 43: no-no. DOI: 10.1002/chin.201210212  0.064
2006 Zhang YM, Fan X, Xiang B, Chakravarty D, Scannevin R, Burke S, Karnachi P, Rhodes K, Jackson P. Synthesis and SAR of α-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors Bioorganic and Medicinal Chemistry Letters. 16: 3096-3100. DOI: 10.1016/j.bmcl.2006.03.065  0.059
2008 Painter J, Snyder J, Rhodes K, Deisher C. The Effect of Visibility and Accessibility of Food on Dietary Intake Journal of the American Dietetic Association. 108: A93. DOI: 10.1016/j.jada.2008.06.258  0.01
Hide low-probability matches.